TY - JOUR
T1 - Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
AU - Odin, Per
AU - Chaudhuri, K. Ray
AU - Volkmann, Jens
AU - Antonini, Angelo
AU - Storch, Alexander
AU - Dietrichs, Espen
AU - Pirtošek, Zvezdan
AU - Henriksen, Tove
AU - Horne, Malcolm
AU - Devos, David
AU - Bergquist, Filip
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.
AB - Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.
UR - http://www.scopus.com/inward/record.url?scp=85052232531&partnerID=8YFLogxK
U2 - 10.1038/s41531-018-0051-7
DO - 10.1038/s41531-018-0051-7
M3 - Review article
AN - SCOPUS:85052232531
SN - 2373-8057
VL - 4
JO - npj Parkinson's Disease
JF - npj Parkinson's Disease
IS - 1
M1 - 14
ER -